Incidence and risk factors for osteonecrosis of the hip in renal transplant patients: a prospective single-centre study.


Journal

International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431

Informations de publication

Date de publication:
10 2020
Historique:
received: 19 05 2020
accepted: 17 06 2020
pubmed: 25 6 2020
medline: 15 4 2021
entrez: 25 6 2020
Statut: ppublish

Résumé

There is a lack of evidence about the risk factors associated with osteonecrosis of the femoral head (ONFH). To determine the incidence and risk factors for ONFH following renal transplantation (RT). In total, data of 681 RT patients (mean age at surgery, 49.5 ± 13.6 years; 249 women and 432 men) were evaluated to determine the incidence of ONFH. Hip magnetic resonance imaging (MRI) was performed six months after RT. The following potential predictors of ONFH were evaluated: (1) patient's condition at RT; laboratory test results including calcium (Ca), phosphorus (P), calcium-phosphorus product (Ca × P), and intact parathyroid hormone before RT; blood relationship between the patient and donor; and mismatching number of human leukocyte antigens (HLAs), especially HLA class I and class II and (2) dosages of steroids after RT, immunosuppressive regimen, and incidence of acute rejection. ONFH was observed in 30 hips (21 cases, 3.1%). We successfully matched 63 patients without ONFH. Multivariate logistic regression analysis, adjusted for cumulative dosages of steroids, revealed that mismatching number of HLA (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.10-2.36; p = 0.014), HLA class II (HR, 3.73; 95% CI, 1.46-9.56; p = 0.001), P before RT (HR, 1.62; 95% CI, 1.02-2.58; p = 0.041), and Ca × P  before RT (HR, 1.06; 95% CI, 1.01-1.11; p = 0.024) were risk factors for ONFH. A greater number of HLA mismatches, HLA class II, serum P, and serum Ca × P were risk factors for ONFH after RT. Therefore, these factors should be evaluated in order to predict ONFH after RT.

Sections du résumé

BACKGROUND
There is a lack of evidence about the risk factors associated with osteonecrosis of the femoral head (ONFH).
PURPOSES
To determine the incidence and risk factors for ONFH following renal transplantation (RT).
METHODS
In total, data of 681 RT patients (mean age at surgery, 49.5 ± 13.6 years; 249 women and 432 men) were evaluated to determine the incidence of ONFH. Hip magnetic resonance imaging (MRI) was performed six months after RT. The following potential predictors of ONFH were evaluated: (1) patient's condition at RT; laboratory test results including calcium (Ca), phosphorus (P), calcium-phosphorus product (Ca × P), and intact parathyroid hormone before RT; blood relationship between the patient and donor; and mismatching number of human leukocyte antigens (HLAs), especially HLA class I and class II and (2) dosages of steroids after RT, immunosuppressive regimen, and incidence of acute rejection.
RESULTS
ONFH was observed in 30 hips (21 cases, 3.1%). We successfully matched 63 patients without ONFH. Multivariate logistic regression analysis, adjusted for cumulative dosages of steroids, revealed that mismatching number of HLA (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.10-2.36; p = 0.014), HLA class II (HR, 3.73; 95% CI, 1.46-9.56; p = 0.001), P before RT (HR, 1.62; 95% CI, 1.02-2.58; p = 0.041), and Ca × P  before RT (HR, 1.06; 95% CI, 1.01-1.11; p = 0.024) were risk factors for ONFH.
CONCLUSION
A greater number of HLA mismatches, HLA class II, serum P, and serum Ca × P were risk factors for ONFH after RT. Therefore, these factors should be evaluated in order to predict ONFH after RT.

Identifiants

pubmed: 32577876
doi: 10.1007/s00264-020-04668-w
pii: 10.1007/s00264-020-04668-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1927-1933

Auteurs

Yoshitoshi Higuchi (Y)

Department of Orthopaedic Surgery, Japanese Red Cross Nagoya Daini Hospital, 2-9 Myouken-cho Showa-ku, Nagoya, 466-8650, Japan. rdggd215@yahoo.co.jp.

Toshihide Tomosugi (T)

Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Kenta Futamura (K)

Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Manabu Okada (M)

Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Shunji Narumi (S)

Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Yoshihiko Watarai (Y)

Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Yoshitaka Suzuki (Y)

Department of Orthopaedic Surgery, Japanese Red Cross Nagoya Daini Hospital, 2-9 Myouken-cho Showa-ku, Nagoya, 466-8650, Japan.

Norihiko Goto (N)

Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Toshihiro Ando (T)

Department of Orthopaedic Surgery, Japanese Red Cross Nagoya Daini Hospital, 2-9 Myouken-cho Showa-ku, Nagoya, 466-8650, Japan.

Koji Sato (K)

Department of Orthopaedic Surgery, Japanese Red Cross Nagoya Daini Hospital, 2-9 Myouken-cho Showa-ku, Nagoya, 466-8650, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH